The Plasma Fraction market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Plasma Fraction market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Plasma Fraction global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Protease Inhibitors segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Plasma Fraction include Baxter, Octapharma, Biotest, CSL, and Grifols, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Plasma Fraction market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Protease Inhibitors
Protease
Fibrinolytic Proteins
Coagulation Factors
Anti-Coagulant Proteins
Market segment by Application, can be divided into
Hospitals
Clinics
Ambulatory Surgical Centers
Market segment by players, this report covers
Baxter
Octapharma
Biotest
CSL
Grifols
Kedrion
LFB
Chinese Biological Products
Shanghai RAAS Blood Products
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Plasma Fraction product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Plasma Fraction, with revenue, gross margin and global market share of Plasma Fraction from 2019 to 2022.
Chapter 3, the Plasma Fraction competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Plasma Fraction market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Plasma Fraction research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Product Overview and Scope of Plasma Fraction
1.2 Classification of Plasma Fraction by Type
1.2.1 Overview: Global Plasma Fraction Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Plasma Fraction Revenue Market Share by Type in 2021
1.2.3 Protease Inhibitors
1.2.4 Protease
1.2.5 Fibrinolytic Proteins
1.2.6 Coagulation Factors
1.2.7 Anti-Coagulant Proteins
1.3 Global Plasma Fraction Market by Application
1.3.1 Overview: Global Plasma Fraction Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Global Plasma Fraction Market Size & Forecast
1.5 Global Plasma Fraction Market Size and Forecast by Region
1.5.1 Global Plasma Fraction Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Plasma Fraction Market Size by Region, (2017-2022)
1.5.3 North America Plasma Fraction Market Size and Prospect (2017-2028)
1.5.4 Europe Plasma Fraction Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Plasma Fraction Market Size and Prospect (2017-2028)
1.5.6 South America Plasma Fraction Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Plasma Fraction Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Plasma Fraction Market Drivers
1.6.2 Plasma Fraction Market Restraints
1.6.3 Plasma Fraction Trends Analysis
2 Company Profiles
2 Company Profiles
2.1 Baxter
2.1.1 Baxter Details
2.1.2 Baxter Major Business
2.1.3 Baxter Plasma Fraction Product and Solutions
2.1.4 Baxter Plasma Fraction Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Baxter Recent Developments and Future Plans
2.2 Octapharma
2.2.1 Octapharma Details
2.2.2 Octapharma Major Business
2.2.3 Octapharma Plasma Fraction Product and Solutions
2.2.4 Octapharma Plasma Fraction Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Octapharma Recent Developments and Future Plans
2.3 Biotest
2.3.1 Biotest Details
2.3.2 Biotest Major Business
2.3.3 Biotest Plasma Fraction Product and Solutions
2.3.4 Biotest Plasma Fraction Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Biotest Recent Developments and Future Plans
2.4 CSL
2.4.1 CSL Details
2.4.2 CSL Major Business
2.4.3 CSL Plasma Fraction Product and Solutions
2.4.4 CSL Plasma Fraction Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 CSL Recent Developments and Future Plans
2.5 Grifols
2.5.1 Grifols Details
2.5.2 Grifols Major Business
2.5.3 Grifols Plasma Fraction Product and Solutions
2.5.4 Grifols Plasma Fraction Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Grifols Recent Developments and Future Plans
2.6 Kedrion
2.6.1 Kedrion Details
2.6.2 Kedrion Major Business
2.6.3 Kedrion Plasma Fraction Product and Solutions
2.6.4 Kedrion Plasma Fraction Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Kedrion Recent Developments and Future Plans
2.7 LFB
2.7.1 LFB Details
2.7.2 LFB Major Business
2.7.3 LFB Plasma Fraction Product and Solutions
2.7.4 LFB Plasma Fraction Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 LFB Recent Developments and Future Plans
2.8 Chinese Biological Products
2.8.1 Chinese Biological Products Details
2.8.2 Chinese Biological Products Major Business
2.8.3 Chinese Biological Products Plasma Fraction Product and Solutions
2.8.4 Chinese Biological Products Plasma Fraction Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Chinese Biological Products Recent Developments and Future Plans
2.9 Shanghai RAAS Blood Products
2.9.1 Shanghai RAAS Blood Products Details
2.9.2 Shanghai RAAS Blood Products Major Business
2.9.3 Shanghai RAAS Blood Products Plasma Fraction Product and Solutions
2.9.4 Shanghai RAAS Blood Products Plasma Fraction Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Shanghai RAAS Blood Products Recent Developments and Future Plans
3 Market Competition, by Players
3 Market Competition, by Players
3.1 Global Plasma Fraction Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Plasma Fraction Players Market Share in 2021
3.2.2 Top 10 Plasma Fraction Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Plasma Fraction Players Head Office, Products and Services Provided
3.4 Plasma Fraction Mergers & Acquisitions
3.5 Plasma Fraction New Entrants and Expansion Plans
4 Market Size Segment by Type
4 Market Size Segment by Type
4.1 Global Plasma Fraction Revenue and Market Share by Type (2017-2022)
4.2 Global Plasma Fraction Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5 Market Size Segment by Application
5.1 Global Plasma Fraction Revenue Market Share by Application (2017-2022)
5.2 Global Plasma Fraction Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6 North America by Country, by Type, and by Application
6.1 North America Plasma Fraction Revenue by Type (2017-2028)
6.2 North America Plasma Fraction Revenue by Application (2017-2028)
6.3 North America Plasma Fraction Market Size by Country
6.3.1 North America Plasma Fraction Revenue by Country (2017-2028)
6.3.2 United States Plasma Fraction Market Size and Forecast (2017-2028)
6.3.3 Canada Plasma Fraction Market Size and Forecast (2017-2028)
6.3.4 Mexico Plasma Fraction Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
7.1 Europe Plasma Fraction Revenue by Type (2017-2028)
7.2 Europe Plasma Fraction Revenue by Application (2017-2028)
7.3 Europe Plasma Fraction Market Size by Country
7.3.1 Europe Plasma Fraction Revenue by Country (2017-2028)
7.3.2 Germany Plasma Fraction Market Size and Forecast (2017-2028)
7.3.3 France Plasma Fraction Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Plasma Fraction Market Size and Forecast (2017-2028)
7.3.5 Russia Plasma Fraction Market Size and Forecast (2017-2028)
7.3.6 Italy Plasma Fraction Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Plasma Fraction Revenue by Type (2017-2028)
8.2 Asia-Pacific Plasma Fraction Revenue by Application (2017-2028)
8.3 Asia-Pacific Plasma Fraction Market Size by Region
8.3.1 Asia-Pacific Plasma Fraction Revenue by Region (2017-2028)
8.3.2 China Plasma Fraction Market Size and Forecast (2017-2028)
8.3.3 Japan Plasma Fraction Market Size and Forecast (2017-2028)
8.3.4 South Korea Plasma Fraction Market Size and Forecast (2017-2028)
8.3.5 India Plasma Fraction Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Plasma Fraction Market Size and Forecast (2017-2028)
8.3.7 Australia Plasma Fraction Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9 South America by Country, by Type, and by Application
9.1 South America Plasma Fraction Revenue by Type (2017-2028)
9.2 South America Plasma Fraction Revenue by Application (2017-2028)
9.3 South America Plasma Fraction Market Size by Country
9.3.1 South America Plasma Fraction Revenue by Country (2017-2028)
9.3.2 Brazil Plasma Fraction Market Size and Forecast (2017-2028)
9.3.3 Argentina Plasma Fraction Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Plasma Fraction Revenue by Type (2017-2028)
10.2 Middle East & Africa Plasma Fraction Revenue by Application (2017-2028)
10.3 Middle East & Africa Plasma Fraction Market Size by Country
10.3.1 Middle East & Africa Plasma Fraction Revenue by Country (2017-2028)
10.3.2 Turkey Plasma Fraction Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Plasma Fraction Market Size and Forecast (2017-2028)
10.3.4 UAE Plasma Fraction Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
11 Research Findings and Conclusion
12 Appendix
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Plasma Fraction Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Plasma Fraction Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Plasma Fraction Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Plasma Fraction Revenue (USD Million) by Region (2017-2022)
Table 5. Global Plasma Fraction Revenue Market Share by Region (2023-2028)
Table 6. Baxter Corporate Information, Head Office, and Major Competitors
Table 7. Baxter Major Business
Table 8. Baxter Plasma Fraction Product and Solutions
Table 9. Baxter Plasma Fraction Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Octapharma Corporate Information, Head Office, and Major Competitors
Table 11. Octapharma Major Business
Table 12. Octapharma Plasma Fraction Product and Solutions
Table 13. Octapharma Plasma Fraction Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Biotest Corporate Information, Head Office, and Major Competitors
Table 15. Biotest Major Business
Table 16. Biotest Plasma Fraction Product and Solutions
Table 17. Biotest Plasma Fraction Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. CSL Corporate Information, Head Office, and Major Competitors
Table 19. CSL Major Business
Table 20. CSL Plasma Fraction Product and Solutions
Table 21. CSL Plasma Fraction Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Grifols Corporate Information, Head Office, and Major Competitors
Table 23. Grifols Major Business
Table 24. Grifols Plasma Fraction Product and Solutions
Table 25. Grifols Plasma Fraction Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Kedrion Corporate Information, Head Office, and Major Competitors
Table 27. Kedrion Major Business
Table 28. Kedrion Plasma Fraction Product and Solutions
Table 29. Kedrion Plasma Fraction Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. LFB Corporate Information, Head Office, and Major Competitors
Table 31. LFB Major Business
Table 32. LFB Plasma Fraction Product and Solutions
Table 33. LFB Plasma Fraction Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Chinese Biological Products Corporate Information, Head Office, and Major Competitors
Table 35. Chinese Biological Products Major Business
Table 36. Chinese Biological Products Plasma Fraction Product and Solutions
Table 37. Chinese Biological Products Plasma Fraction Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Shanghai RAAS Blood Products Corporate Information, Head Office, and Major Competitors
Table 39. Shanghai RAAS Blood Products Major Business
Table 40. Shanghai RAAS Blood Products Plasma Fraction Product and Solutions
Table 41. Shanghai RAAS Blood Products Plasma Fraction Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Global Plasma Fraction Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 43. Global Plasma Fraction Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 44. Breakdown of Plasma Fraction by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Plasma Fraction Players Head Office, Products and Services Provided
Table 46. Plasma Fraction Mergers & Acquisitions in the Past Five Years
Table 47. Plasma Fraction New Entrants and Expansion Plans
Table 48. Global Plasma Fraction Revenue (USD Million) by Type (2017-2022)
Table 49. Global Plasma Fraction Revenue Share by Type (2017-2022)
Table 50. Global Plasma Fraction Revenue Forecast by Type (2023-2028)
Table 51. Global Plasma Fraction Revenue by Application (2017-2022)
Table 52. Global Plasma Fraction Revenue Forecast by Application (2023-2028)
Table 53. North America Plasma Fraction Revenue by Type (2017-2022) & (USD Million)
Table 54. North America Plasma Fraction Revenue by Type (2023-2028) & (USD Million)
Table 55. North America Plasma Fraction Revenue by Application (2017-2022) & (USD Million)
Table 56. North America Plasma Fraction Revenue by Application (2023-2028) & (USD Million)
Table 57. North America Plasma Fraction Revenue by Country (2017-2022) & (USD Million)
Table 58. North America Plasma Fraction Revenue by Country (2023-2028) & (USD Million)
Table 59. Europe Plasma Fraction Revenue by Type (2017-2022) & (USD Million)
Table 60. Europe Plasma Fraction Revenue by Type (2023-2028) & (USD Million)
Table 61. Europe Plasma Fraction Revenue by Application (2017-2022) & (USD Million)
Table 62. Europe Plasma Fraction Revenue by Application (2023-2028) & (USD Million)
Table 63. Europe Plasma Fraction Revenue by Country (2017-2022) & (USD Million)
Table 64. Europe Plasma Fraction Revenue by Country (2023-2028) & (USD Million)
Table 65. Asia-Pacific Plasma Fraction Revenue by Type (2017-2022) & (USD Million)
Table 66. Asia-Pacific Plasma Fraction Revenue by Type (2023-2028) & (USD Million)
Table 67. Asia-Pacific Plasma Fraction Revenue by Application (2017-2022) & (USD Million)
Table 68. Asia-Pacific Plasma Fraction Revenue by Application (2023-2028) & (USD Million)
Table 69. Asia-Pacific Plasma Fraction Revenue by Region (2017-2022) & (USD Million)
Table 70. Asia-Pacific Plasma Fraction Revenue by Region (2023-2028) & (USD Million)
Table 71. South America Plasma Fraction Revenue by Type (2017-2022) & (USD Million)
Table 72. South America Plasma Fraction Revenue by Type (2023-2028) & (USD Million)
Table 73. South America Plasma Fraction Revenue by Application (2017-2022) & (USD Million)
Table 74. South America Plasma Fraction Revenue by Application (2023-2028) & (USD Million)
Table 75. South America Plasma Fraction Revenue by Country (2017-2022) & (USD Million)
Table 76. South America Plasma Fraction Revenue by Country (2023-2028) & (USD Million)
Table 77. Middle East & Africa Plasma Fraction Revenue by Type (2017-2022) & (USD Million)
Table 78. Middle East & Africa Plasma Fraction Revenue by Type (2023-2028) & (USD Million)
Table 79. Middle East & Africa Plasma Fraction Revenue by Application (2017-2022) & (USD Million)
Table 80. Middle East & Africa Plasma Fraction Revenue by Application (2023-2028) & (USD Million)
Table 81. Middle East & Africa Plasma Fraction Revenue by Country (2017-2022) & (USD Million)
Table 82. Middle East & Africa Plasma Fraction Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Plasma Fraction Picture
Figure 2. Global Plasma Fraction Revenue Market Share by Type in 2021
Figure 3. Protease Inhibitors
Figure 4. Protease
Figure 5. Fibrinolytic Proteins
Figure 6. Coagulation Factors
Figure 7. Anti-Coagulant Proteins
Figure 8. Plasma Fraction Revenue Market Share by Application in 2021
Figure 9. Hospitals Picture
Figure 10. Clinics Picture
Figure 11. Ambulatory Surgical Centers Picture
Figure 12. Global Plasma Fraction Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Plasma Fraction Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Plasma Fraction Revenue Market Share by Region (2017-2028)
Figure 15. Global Plasma Fraction Revenue Market Share by Region in 2021
Figure 16. North America Plasma Fraction Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Plasma Fraction Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Plasma Fraction Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Plasma Fraction Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Plasma Fraction Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Plasma Fraction Market Drivers
Figure 22. Plasma Fraction Market Restraints
Figure 23. Plasma Fraction Market Trends
Figure 24. Baxter Recent Developments and Future Plans
Figure 25. Octapharma Recent Developments and Future Plans
Figure 26. Biotest Recent Developments and Future Plans
Figure 27. CSL Recent Developments and Future Plans
Figure 28. Grifols Recent Developments and Future Plans
Figure 29. Kedrion Recent Developments and Future Plans
Figure 30. LFB Recent Developments and Future Plans
Figure 31. Chinese Biological Products Recent Developments and Future Plans
Figure 32. Shanghai RAAS Blood Products Recent Developments and Future Plans
Figure 33. Global Plasma Fraction Revenue Share by Players in 2021
Figure 34. Plasma Fraction Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 35. Global Top 3 Players Plasma Fraction Revenue Market Share in 2021
Figure 36. Global Top 10 Players Plasma Fraction Revenue Market Share in 2021
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 38. Global Plasma Fraction Revenue Share by Type in 2021
Figure 39. Global Plasma Fraction Market Share Forecast by Type (2023-2028)
Figure 40. Global Plasma Fraction Revenue Share by Application in 2021
Figure 41. Global Plasma Fraction Market Share Forecast by Application (2023-2028)
Figure 42. North America Plasma Fraction Sales Market Share by Type (2017-2028)
Figure 43. North America Plasma Fraction Sales Market Share by Application (2017-2028)
Figure 44. North America Plasma Fraction Revenue Market Share by Country (2017-2028)
Figure 45. United States Plasma Fraction Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Canada Plasma Fraction Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Mexico Plasma Fraction Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Europe Plasma Fraction Sales Market Share by Type (2017-2028)
Figure 49. Europe Plasma Fraction Sales Market Share by Application (2017-2028)
Figure 50. Europe Plasma Fraction Revenue Market Share by Country (2017-2028)
Figure 51. Germany Plasma Fraction Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Plasma Fraction Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Plasma Fraction Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Plasma Fraction Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Plasma Fraction Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Plasma Fraction Sales Market Share by Type (2017-2028)
Figure 57. Asia-Pacific Plasma Fraction Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Plasma Fraction Revenue Market Share by Region (2017-2028)
Figure 59. China Plasma Fraction Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Plasma Fraction Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South Korea Plasma Fraction Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Plasma Fraction Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Plasma Fraction Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Plasma Fraction Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Plasma Fraction Sales Market Share by Type (2017-2028)
Figure 66. South America Plasma Fraction Sales Market Share by Application (2017-2028)
Figure 67. South America Plasma Fraction Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Plasma Fraction Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Plasma Fraction Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East and Africa Plasma Fraction Sales Market Share by Type (2017-2028)
Figure 71. Middle East and Africa Plasma Fraction Sales Market Share by Application (2017-2028)
Figure 72. Middle East and Africa Plasma Fraction Revenue Market Share by Country (2017-2028)
Figure 73. Turkey Plasma Fraction Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Plasma Fraction Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. UAE Plasma Fraction Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source